4.8 Article

Lnc-ing ROR1-HER3 and Hippo signalling in metastasis

Related references

Note: Only part of the references are listed.
Article Oncology

The emerging roles of YAP and TAZ in cancer

Toshiro Moroishi et al.

NATURE REVIEWS CANCER (2015)

Review Biotechnology & Applied Microbiology

The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment

Randy Johnson et al.

NATURE REVIEWS DRUG DISCOVERY (2014)

Review Cell Biology

ROR1, an embryonic protein with an emerging role in cancer biology

Nicholas Borcherding et al.

PROTEIN & CELL (2014)

Review Cell Biology

RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts

Sarah Geisler et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)

Article Multidisciplinary Sciences

Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1

Run Fan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Biochemistry & Molecular Biology

LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker

Dahu Chen et al.

NATURE MEDICINE (2012)

Review Oncology

Cancer to bone: a fatal attraction

Katherine N. Weilbaecher et al.

NATURE REVIEWS CANCER (2011)

Article Multidisciplinary Sciences

Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3

Natalia V. Sergina et al.

NATURE (2007)

Article Endocrinology & Metabolism

Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer

Tsuyoshi Shimo et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2006)